Suita, Japan

Takashi Kamiya

This inventor holds 56 USPTO granted patents, primarily in Pharmaceutical Chemistry (CPC class 544 ). Top assignees: Fujisawa Pharmaceutical Company, Ltd., Other. Active years: 1976-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 391(Granted Patents)

Forward Citations (Not Self Cited) = 370(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Suita, JA (1976 - 1978)
  • Suita, JP (1978 - 2001)

Company Filing History:


Years Active: 1976-2001

Loading Chart...
Areas of Expertise:
Cephem Compounds
Azetidinone Derivatives
Thiazole Derivatives
Disulfide Substituted
Pyrimidinyl Derivatives
Penam Derivatives
Amino Compounds
Oxazetidine Derivatives
Carboxylic Acids
Bicyclomycin Derivatives
Hydroxyamino Derivatives
Phenylacetic Acid Compounds
56 patents (USPTO):Explore Patents

Title: The Innovative Journey of Takashi Kamiya

Introduction:

Takashi Kamiya, a pioneering inventor hailing from Suita, Japan, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Kamiya's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable health monitoring devices, and sustainable energy solutions.

Career Highlights:

With a career spanning over two decades, Takashi Kamiya has worked with leading tech companies in Japan, spearheading research and development projects that have led to the creation of cutting-edge products and technologies.

Collaborations:

Throughout his career, Kamiya has collaborated with top researchers and engineers from renowned universities and research institutions in Japan, fostering a culture of innovation and knowledge sharing.

Conclusion:

In conclusion, Takashi Kamiya's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a visionary inventor in the global tech community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…